R
Richter Gedeon Vegyeszeti Gyar Nyrt
BET:RICHTER
Richter Gedeon Vegyeszeti Gyar Nyrt
BET:RICHTER
Price:
11 670
HUF
7.96%
Market Closed
Market Cap:
Ft2.2T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Richter Gedeon Vegyeszeti Gyar Nyrt
BET:RICHTER
|
HU |
|
Zhejiang Fuchunjiang Environmental Thermoelectric Co Ltd
SZSE:002479
|
CN |
|
C
|
Colabor Group Inc
TSX:GCL
|
CA |
|
S
|
Sarawak Consolidated Industries Bhd
KLSE:SCIB
|
MY |
|
F
|
Fulcrum Metals PLC
LSE:FMET
|
UK |
|
A
|
Aegon NV
MIL:AGN
|
NL |
|
F
|
Fabrinet
SWB:FAN
|
US |
|
C
|
Candela Invest SA
XBRU:CAND
|
BE |
Multiples-Based Value
The Multiples-Based Value of one RICHTER stock under the Base Case scenario is hidden HUF. Compared to the current market price of 11 670 HUF, Richter Gedeon Vegyeszeti Gyar Nyrt is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RICHTER Multiples-Based Value
LOCKED
Multiples Across Competitors
RICHTER Competitors Multiples
Richter Gedeon Vegyeszeti Gyar Nyrt Competitors
Richter Gedeon Vegyeszeti Gyar Nyrt Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HU |
R
|
Richter Gedeon Vegyeszeti Gyar Nyrt
BET:RICHTER
|
1.9T HUF | 2.1 | 8.6 | 5 | 6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.7 | 40.2 | 27.2 | 29 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.6 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 9.8 | 7.3 | 8.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.4 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
